Ian A. Cook

Technik-/Wissenschafts-/F&E-Leiter bei NeuroSigma, Inc.

64 Jahre

Consumer Services

Health Technology

Aktive Positionen von Ian A. Cook

Unternehmen	Position	Beginn	Ende
NeuroSigma, Inc. NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2014	-
Henry Samueli School of Engineering & Applied Science	Corporate Officer/Principal	01.07.2013	-
David Geffen School of Medicine	Corporate Officer/Principal	01.07.2010	-
Semel Institute For Neuroscience & Human Behavior	Corporate Officer/Principal	01.01.2007	-

Princeton University	Undergraduate Degree
Yale School of Medicine	Doctorate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Undergraduate Degree	1

Sektoral

Consumer Services	6
Health Technology	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
NeuroSigma, Inc. NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA.	Health Technology

Private Unternehmen

Health Technology